CRO for Clinical Trials in the EU
The European Union (EU) is one of the world’s most important territories to conduct clinical trials. Several EU countries (like Germany, France, or Spain) are worldwide leaders in the number of clinical trials performed every year.
In the EU, approximately 4,000 clinical trials are authorized annually. This equals approximately 8,000 clinical trial applications, with each trial involving two EU Member States on average. Nearly 61% of clinical trials are sponsored by the pharmaceutical industry and 39% by non-commercial sponsors, mainly academia.
Sofpromed offers high-quality CRO services for biotechnology and pharmaceutical companies planning to conduct their phase I-IV clinical trials in the European Union.
Our CRO services in the EU include:
- Regulatory
- Clinical operations
- Site selection and activation
- Site management
- Monitoring
- Data management
- Biostatistics
- Statistical programming
- Medical writing
- Clinical trial logistics
Among others, we are able to manage clinical studies in the following therapeutic areas in the EU:
- Oncology
- Hematology
- Cardiovascular
- Metabolic
- Central nervous system (CNS)
- Dermatology
- Infectious diseases
- Respiratory diseases
- Pain